kabutan

HOGY MEDICAL, 22% Increase in Ordinary Profit for The Current Fiscal Year, Dividend Raised by 15 yen

Thu Apr 24, 2025 3:30 pm JST Earnings

3593 HOGY MEDICAL CO.,LTD. 【J-GAAP】

Earnings Report

HOGY MEDICAL CO.,LTD. <3593> [TSE Prime] announced its financial results after the market closed on April 24th (15:30). The consolidated ordinary profit for the fiscal year ending March 2025 decreased 14.1% from the previous period to 3.64 billion yen. In the fiscal year ending March 2026, the profit is expected to expand to 21.5% to 4.43 billion yen. This will be the fifth consecutive term of revenue growth.

At the same time, Final dividend of 20 yen for the previous fiscal year (Annual dividend is 80 yen), and has decided to increase the dividend this fiscal year to 95 yen, an increase of 15 yen from the previous fiscal year.

In the most recent three-month period, from January to March (4Q), the consolidated ordinary profit dropped to 0.37 billion yen, a 42.9% decrease compared to the same period last year. The operating profit margin worsened from 7.3% in the same period last year to 4.4%.

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2023 38,981 6,634 6,653 4,316 178.0 71 Apr 12, 2023 J-GAAP
Mar, 2024 39,100 4,169 4,245 2,804 115.6 80 Apr 10, 2024 J-GAAP
Mar, 2025 39,138 3,810 3,645 1,520 68.0 80 Apr 24, 2025 J-GAAP
YoY +0.1% -8.6% -14.1% -45.8% -41.2%

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2025 Guidance 39,110 3,740 3,570 1,890 87.7 80 Mar 31, 2025 J-GAAP
Mar, 2025 Results 39,138 3,810 3,645 1,520 68.0 80 Apr 24, 2025 J-GAAP
Revision Rate +0.1% +1.9% +2.1% -19.6% -22.5%

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2024 19,619 2,083 2,036 1,867 80.6 40 Oct 10, 2024 J-GAAP
Apr - Sep, 2025 Guidance 20,170 1,840 1,900 1,300 60.3 47.50 Apr 24, 2025 J-GAAP
YoY +2.8% -11.7% -6.7% -30.4% -25.2%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 39,100 4,169 4,245 2,804 115.6 80 Apr 10, 2024 J-GAAP
Mar, 2025 39,138 3,810 3,645 1,520 68.0 80 Apr 24, 2025 J-GAAP
Mar, 2026 Guidance 41,790 4,300 4,430 3,020 140.1 95 Apr 24, 2025 J-GAAP
YoY +6.8% +12.9% +21.5% +98.7% +106.1%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jan - Mar, 2024 9,346 682 658 195 8.0 7.3 Apr 10, 2024 J-GAAP
Apr - Jun, 2024 9,725 1,335 1,405 1,006 41.5 13.7 Jul 10, 2024 J-GAAP
Jul - Sep, 2024 9,894 748 631 861 37.2 7.6 Oct 10, 2024 J-GAAP
Oct - Dec, 2024 10,397 1,323 1,233 869 38.4 12.7 Jan 16, 2025 J-GAAP
Jan - Mar, 2025 9,122 404 376 -1,216 -54.4 4.4 Apr 24, 2025 J-GAAP
YoY -2.4% -40.8% -42.9% － －

Related Articles